SCHEMBL3345975

SCHEMBL3345975

Cc1ccc2cc3c(c(O)cc4ccccc43)c3c2c1CC3

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.67
ALDH1A1 P00352 5/20 0.67
MAPT P10636 5/20 0.67
FYN P06241 2/20 0.67
ACHE P22303 2/20 0.67
AHR P35869 2/20 0.67
LCK P06239 1/20 0.67
ADORA3 P0DMS8 1/20 0.67
SLC6A2 P23975 1/20 0.67
TRPM4 Q8TD43 1/20 0.43
HSD17B10 Q99714 2/20 0.39
HIF1A Q16665 1/20 0.39
CYP1B1 Q16678 1/20 0.39
HPGD P15428 3/20 0.38
ERBB2 P04626 1/20 0.37
MAOA P21397 1/20 0.37
CYP2A6 P11509 2/20 0.36
TSHR P16473 1/20 0.36
NQO2 P16083 1/20 0.35
LMNA P02545 5/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Methylcholanthrene SCHEMBL29397062 0.80 ALDH1A1 (1.00) CYP1A2ALDH1A1MAPTFYNACHE
3-Methylcholanthrene SCHEMBL156129 0.80 ALDH1A1 (1.00) CYP1A2ALDH1A1MAPTFYNACHE
3-Methylcholanthrene SCHEMBL29444145 0.80 ALDH1A1 (1.00) CYP1A2ALDH1A1MAPTFYNACHE
3-Methylcholanthrene SCHEMBL27621124 0.79 ALDH1A1 (0.97) CYP1A2ALDH1A1MAPTFYNACHE
3-Methylcholanthrene SCHEMBL2958054 0.79 ALDH1A1 (0.97) CYP1A2ALDH1A1MAPTFYNACHE
SCHEMBL3345967 0.75 CYP1A2 (0.57) CYP1A2ALDH1A1MAPTFYNACHE
SCHEMBL4947995 0.69 CYP1A2 (0.53) CYP1A2ALDH1A1MAPTFYNACHE
SCHEMBL30712558 0.69 ALDH1A1 (0.53) CYP1A2ALDH1A1MAPTFYNACHE
SCHEMBL29093506 0.69 ALDH1A1 (0.53) CYP1A2ALDH1A1MAPTFYNACHE
SCHEMBL25622486 0.67 TRPM4 (0.59) CYP1A2ALDH1A1MAPTFYNACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100162416-A1 Multi-stage stem cell carcinogenesis STEMLIFELINE, INC. (US) 2010-06-24 US disclosed